Abstract:440 Background: Massive Transfusion Protocol (MTP) is a term used to describe a process to deliver blood products rapidly to treat life-threatening hemorrhage. MTPs follow a prescribed algorithm to efficiently replace blood products in set ratios. Three components of MTP include immediate availability of blood products, set types and ratios of blood products, and standardized roles for health care providers. MTP is associated with decreased morbidity and mortality compared to provider-driven decisions on blood transfusion. Methods: The Quality Improvement Assessment Board approved this initiative to standardize and create an MTP process outside of the Operating Room (OR). We assembled a multidisciplinary team to review and adopt evidence-based practices for MTP. A core group of content experts developed the relevant policy and protocol for activation and use of MTP in the Intensive Care Unit (ICU), Pediatric Intensive Care Unit (PICU), Emergency Room (ER), Interventional Radiology (IR) and inpatient floor. Simulations were held in these areas and Plan Do Study Act (PDSA) cycles used to improve the processes. Improvements included adjustment to the quantity and type of emergency release products immediately available, the timing of when platelets were delivered to providers and development of a ‘pull’ process for the Blood Bank to prepare additional blood products minimizing wastage. Following these changes, the MTP process became consistent and could be activated from all of the targeted locations. Each MTP episode was reviewed for outcomes and efficiency metrics. We held multidisciplinary care debriefings to review hemorrhagic events for areas of improvement. The OR had an existing process that was separate from this initiative, but will be aligned June 2023 and included in future analysis. Results: Baseline, from January 2022 to September 2022, 32 massive transfusion events occurred (3.5 per month). After implementation of the MTP protocol, from October 2022 to May 2023, the MTP protocol was activated 36 times (4.5 per month). There were 7 (22%) deaths at baseline and 5 (14%) after implementation. The average length of time from activation to receipt of first blood product was 26 minutes at baseline and 25 minutes with MTP. The average number of units administered at baseline included 7.7 units of red blood cells (RBC), 7.6 units fresh frozen plasma (FFP), 1 unit single donor platelets, and 2 units cryoprecipitate compared to after implementation of 6.9 units RBC, 6 units FFP, 1.6 units single donor platelets, and 3 units cryoprecipitate. The ICU was the most common MTP activation location (44%), followed by ER (19%), PICU (17%), the floor (14%) and IR (6%). Conclusions: It is feasible and safe to deploy an MTP throughout an institution. Preliminary data show a decrease in the percentage of patient deaths with use of MTP. Additional analysis are planned to evaluate the incremental improvements made with each PDSA cycle.

Current Opinions on Massive Transfusion Protocol in Trauma Patients

Massive Transfusion Protocol and Outcome of Patients with Acute Variceal Bleeding

Massive transfusion protocol reactivation as a novel marker of physician team under‐triage after injury

Implementation of a hospital-wide massive transfusion protocol at a tertiary cancer center.

Survey of pediatric massive transfusion protocol practice at United States level I trauma centers: An AABB Pediatric Transfusion Medicine Subsection study

Massive transfusion in trauma

Management of massive haemorrhage in transfusion medicine services in the Middle East and North Africa

Blood Transfusion for Major Trauma in Emergency Department

Is there a need for fresh frozen plasma and platelet transfusion in trauma patients receiving submassive transfusion?

Reconsidering Fresh Frozen Plasma Availability to Reduce Blood Product Waste During Massive Transfusion Events in Trauma

Emergency Blood Transfusion for Trauma and Perioperative Resuscitation: Standard of Care

A Scoping Review of Military Combat Casualty Data on Submassive, Massive, and Supermassive Transfusions

Predictors of massive transfusion protocols activation in patients with trauma in Korea: a systematic review

Massive Transfusion Protocols in Obstetric Hemorrhage: Theory versus Reality

Goal-directed transfusion protocol via thrombelastography in patients with abdominal trauma: a retrospective study

Analyzing and modeling massive transfusion strategies and the role of fibrinogen—How much is the patient actually receiving?

Aggressive fresh frozen plasma (FFP) with massive blood transfusion in the absence of acute traumatic coagulopathy

Patient blood management guideline for adults with critical bleeding

Early identification of patients requiring massive transfusion, embolization, or hemostatic surgery for traumatic hemorrhage: a systematic review protocol

Whole blood transfusion versus component therapy in trauma resuscitation: a systematic review and meta‐analysis

Timing to First Whole Blood Transfusion and Survival Following Severe Hemorrhage in Trauma Patients